Ingevity (NGVT)
(Real Time Quote from BATS)
$45.04 USD
+0.60 (1.35%)
Updated Jul 22, 2024 02:53 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Ingevity (NGVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$54.17 | $62.00 | $45.00 | 21.89% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Ingevity comes to $54.17. The forecasts range from a low of $45.00 to a high of $62.00. The average price target represents an increase of 21.89% from the last closing price of $44.44.
Analyst Price Targets (6 )
Broker Rating
Ingevity currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.14 a month ago based on seven recommendations.
Of the six recommendations deriving the current ABR, two are Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/NGVT.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.14 | 2.14 | 2.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/11/2024 | Wells Fargo Securities | Michael J Sison | Hold | Hold |
5/8/2024 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
5/7/2024 | Loop Capital Markets | Christopher Kapsch | Hold | Hold |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
11/6/2023 | CJS Securities | Jonathan Tanwanteng | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 6 |
Average Target Price | $54.17 |
LT Growth Rate | NA |
Industry | Chemical - Specialty |
Industry Rank by ABR | 76 of 252 |
Current Quarter EPS Est: | 0.98 |